AMD vs AMRX · P/E 157, rev $11.54B vs P/E 44, rev $2.79B
Advanced Micro Devices Inc (AMD) versus Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — a side-by-side from cached financials, not a winner call.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Latest reported AMRX revenue for 2024-12-31 was $2.79B. Net income was -$73.9M. Revenue was up 16.7% from 2023-12-31 to 2024-12-31. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
AMD currently screens at market cap $760.48B and trailing P/E 156.5. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Not investment advice. Open the AMD and AMRX stock pages for the full models.
Not investment advice.